Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Evaluate the Safety, Efficacy, Pharmacokinetics of ThisCART19A in Patients With AIDS Related B Cell Lymphoma/Lympholeukemia

NCT05340829 is registered in ClinicalTrials.gov with He Huang as lead sponsor.

NCT NCT05340829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05340829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Evaluate the Safety, Efficacy, Pharmacokinetics of ThisCART19A in Patients With AIDS Related B Cell Lymphoma/Lympholeukemia
Lead sponsor
He Huang
Phase
Phase 1
Overall status
Unknown status
Start date
March 18, 2022
Completion date
April 30, 2024
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aids related lymphoma and lympholeukemia